Clinical Trial: Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653087) titled 'Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma' on June 08.

Brief Summary: This research study is testing a decision aid to help patients think through whether to have sentinel lymph node biopsy for melanoma.

Sentinel lymph node biopsy (SLNB) can be a difficult decision for some patients because the potential benefits and risks may not be clear. This study is being done to learn whether providing structured, easy-to-understand information helps patients feel more informed and less uncertain about their decision.

Patients in this study will be given a paper decision aid (DA). Patients will be...